173 related articles for article (PubMed ID: 36104215)
1. Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth.
Hossen MN; Wang L; Dwivedi SKD; Zhang Y; Rao G; Elechalwar CK; Sheth V; Dey A; Asfa S; Gulla SK; Xu C; Fung KM; Robertson JD; Bieniasz M; Wilhelm S; Bhattacharya R; Mukherjee P
Adv Sci (Weinh); 2022 Nov; 9(31):e2200491. PubMed ID: 36104215
[TBL] [Abstract][Full Text] [Related]
2. The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model.
Razzak R; Zhou J; Yang X; Pervez N; Bédard EL; Moore RB; Shaw A; Amanie J; Roa WH
Clin Invest Med; 2013 Jun; 36(3):E133-42. PubMed ID: 23739667
[TBL] [Abstract][Full Text] [Related]
3. Gold Nanoparticles Conjugated with Glycopeptides for Lectin Detection and Imaging on Cell Surface.
Tsutsumi H; Shirai T; Ohkusa H; Mihara H
Protein Pept Lett; 2018; 25(1):84-89. PubMed ID: 29256341
[TBL] [Abstract][Full Text] [Related]
4. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer.
Geng F; Song K; Xing JZ; Yuan C; Yan S; Yang Q; Chen J; Kong B
Nanotechnology; 2011 Jul; 22(28):285101. PubMed ID: 21654036
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles alter parameters of oxidative stress and energy metabolism in organs of adult rats.
Ferreira GK; Cardoso E; Vuolo FS; Michels M; Zanoni ET; Carvalho-Silva M; Gomes LM; Dal-Pizzol F; Rezin GT; Streck EL; Paula MM
Biochem Cell Biol; 2015 Dec; 93(6):548-57. PubMed ID: 26583437
[TBL] [Abstract][Full Text] [Related]
6. Enhanced intracellular translocation and biodistribution of gold nanoparticles functionalized with a cell-penetrating peptide (VG-21) from vesicular stomatitis virus.
Tiwari PM; Eroglu E; Bawage SS; Vig K; Miller ME; Pillai S; Dennis VA; Singh SR
Biomaterials; 2014 Nov; 35(35):9484-94. PubMed ID: 25154664
[TBL] [Abstract][Full Text] [Related]
7. Targeted dose enhancement in radiotherapy for breast cancer using gold nanoparticles, part 2: A treatment planning study.
Strigari L; Ferrero V; Visonà G; Dalmasso F; Gobbato A; Cerello P; Visentin S; Attili A
Med Phys; 2017 May; 44(5):1993-2001. PubMed ID: 28236658
[TBL] [Abstract][Full Text] [Related]
8. Linalool-Loaded Glutathione-Modified Gold Nanoparticles Conjugated with CALNN Peptide as Apoptosis Inducer and NF-κB Translocation Inhibitor in SKOV-3 Cell Line.
Jabir M; Sahib UI; Taqi Z; Taha A; Sulaiman G; Albukhaty S; Al-Shammari A; Alwahibi M; Soliman D; Dewir YH; Rizwana H
Int J Nanomedicine; 2020; 15():9025-9047. PubMed ID: 33235450
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity.
Zanjanchi P; Asghari SM; Mohabatkar H; Shourian M; Shafiee Ardestani M
J Nanobiotechnology; 2022 Jan; 20(1):7. PubMed ID: 34983556
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels.
Abdelhalim MA
Lipids Health Dis; 2011 Dec; 10():233. PubMed ID: 22151883
[TBL] [Abstract][Full Text] [Related]
11. Increased radiosensitivity of colorectal tumors with intra-tumoral injection of low dose of gold nanoparticles.
Shi M; Paquette B; Thippayamontri T; Gendron L; Guérin B; Sanche L
Int J Nanomedicine; 2016; 11():5323-5333. PubMed ID: 27789945
[TBL] [Abstract][Full Text] [Related]
12. Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer.
Huang TT; Brill E; Nair JR; Zhang X; Wilson KM; Chen L; Thomas CJ; Lee JM
Cancer Res; 2020 Dec; 80(23):5380-5392. PubMed ID: 32998994
[TBL] [Abstract][Full Text] [Related]
13. Completely dispersible PEGylated gold nanoparticles under physiological conditions: modification of gold nanoparticles with precisely controlled PEG-b-polyamine.
Miyamoto D; Oishi M; Kojima K; Yoshimoto K; Nagasaki Y
Langmuir; 2008 May; 24(9):5010-7. PubMed ID: 18386943
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins.
De Araújo RF; Pessoa JB; Cruz LJ; Chan AB; De Castro Miguel E; Cavalcante RS; Brito GAC; Silva HFO; Gasparotto LHS; Guedes PMM; Araújo AA
Int J Oncol; 2018 Jan; 52(1):189-200. PubMed ID: 29115423
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.
Santiskulvong C; Konecny GE; Fekete M; Chen KY; Karam A; Mulholland D; Eng C; Wu H; Song M; Dorigo O
Clin Cancer Res; 2011 Apr; 17(8):2373-84. PubMed ID: 21372221
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, tissue distribution and safety of gold nanoparticle/PKC Delta inhibitor peptide hybrid in rats.
Konoeda H; Takizawa H; Gower A; Zhao M; Adeyi OA; Liu M
Nanotoxicology; 2020 Apr; 14(3):341-354. PubMed ID: 31852291
[TBL] [Abstract][Full Text] [Related]
17. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
Safwat MA; Soliman GM; Sayed D; Attia MA
Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
[TBL] [Abstract][Full Text] [Related]
18. Treating cancer stem cells and cancer metastasis using glucose-coated gold nanoparticles.
Hu C; Niestroj M; Yuan D; Chang S; Chen J
Int J Nanomedicine; 2015; 10():2065-77. PubMed ID: 25844037
[TBL] [Abstract][Full Text] [Related]
19. Dynamic In Vivo X-ray Fluorescence Imaging of Gold in Living Mice Exposed to Gold Nanoparticles.
Jung S; Kim T; Lee W; Kim H; Kim HS; Im HJ; Ye SJ
IEEE Trans Med Imaging; 2020 Feb; 39(2):526-533. PubMed ID: 31380749
[TBL] [Abstract][Full Text] [Related]
20. In vivo activity of combined PI3K/mTOR and MEK inhibition in a Kras(G12D);Pten deletion mouse model of ovarian cancer.
Kinross KM; Brown DV; Kleinschmidt M; Jackson S; Christensen J; Cullinane C; Hicks RJ; Johnstone RW; McArthur GA
Mol Cancer Ther; 2011 Aug; 10(8):1440-9. PubMed ID: 21632463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
